You searched for: booster doses (Engelska - Maltesiska)

booster dose
doża ta’ rinforz

booster doses of synflorix may increase the risk of side effects.
dożi booster ta’ synflorix jistgħu jżidu r-riskju ta’ effetti sekondarji.

booster doses should be given in accordance with the official recommendations.
dożi booster għandhom jingħataw skond ir-rakkomandazzjonijiet uffiċjali.

there are inadequate data to determine the appropriate timing of booster doses.
m’hemmx dejta biżżejjed biex tiddetermina ż-żmien adatt meta għandhom jingħataw dożi booster.

0.25 ml booster dose n=81
0.25 ml doża booster n=81

a booster dose must be given.
għandha tingħata doża booster.

after primary vaccination in infancy, booster doses of hib and menc must be administered.
wara tilqim primarju fi trabi, għandhom jingħataw dożi booster ta ’ hib u menc.

booster dose (children and adolescents)
doża booster (tfal u adolexxenti)

the need for a booster dose is not known.
il-ħtieġa għal doża ta’ rinforz għadha mhux magħrufa.

the need for a booster dose has not been established.
1q mhux rakkomandat għall- użu fit- tfal taħt il- 9 sena għax m’ hemmx biżżejjed informazzjoni dwar l - immunoġeniċità, is- sigurtà u l- effikaċja (ara sezzjoni 5. 1).

the need for a toddler booster dose was seen in this study.
il- ħtieġa ta’ doża buster għal tfal żgħar deher f’dan l-istudju.

2 doses 2 weeks apart with a booster dose 1 year later
sentejn

booster dose should be given in accordance with the official recommendations.
id-doża ta’ riinforz għandha tingħata skont ir- rakkomandazzjonijiet uffiċjali.

a booster dose is recommended before the end of the second year of life.
doża buster hija rrakkomandata qabel it-tmeim tat-tieni sena ta’ ħajja.

a booster dose elicited an anamnestic response indicative of an immune memory.
doża buster qanqlet respons anamnestiku, indikattiv ta’ memorja immunoloġika.

thereafter a single booster dose of 2 ml should be administered every six months.
minn hemm ’il quddiem, għandha tingħata doża booster waħdanija ta’ 2 ml kull 6 xhur.

antibody persistence and booster dose in children and adolescents from a jev-endemic country
persistenza tal-antikorpi u doża booster fi tfal u adolexxenti minn pajjiż b’jev endemiku

the need for a booster dose has not been established (see section 5.1).
il-ħtieġa ta’ doża booster ma ġietx stabbilita (ara s-sezzjoni 5.1).

after a 3-dose primary vaccination with hexacima, a booster dose should be given.
wara tilqim primarju ta tliet dożi b’ hexacima, doża booster għandha tingħata.

a fourth (booster) dose was given in six clinical studies to 1,976 subjects.
ir-raba’ doża (booster) ingħatat f’sitt provi kliniċi lil 1,976 individwu.